These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 14565483)

  • 21. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
    Fukuma T; Walton CM; Wu CH; Wu GY
    Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
    Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The inhibitory effects of hepatocyte targeting pH-sensitive liposome mediated phosphorothioate antisense oligonucleotide on gene expression controlled by HCV 5'NCR].
    Wang XH; Wang SQ; Wen SY; Guan W; Mao BZ
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):626-30. PubMed ID: 11910753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Specific regulatory inhibition of transfected HepG(2) with HCV 5'NCR by antisense phosphorothioate oligodeoxynucleotides].
    Wang S; Wang X; Guan W; Li M
    Zhonghua Gan Zang Bing Za Zhi; 2000 Oct; 8(5):288-90. PubMed ID: 11058954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro.
    Nakazono K; Ito Y; Wu CH; Wu GY
    Hepatology; 1996 Jun; 23(6):1297-303. PubMed ID: 8675142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of hepatitis B viral gene expression and replication in vitro by targeted antisense oligonucleotides].
    Zhong S; Zhang D; Wen S
    Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):392-5, 444. PubMed ID: 7553155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of hepatitis C virus-transfected cholangiocarcinoma by antisense oligodeoxynucleotide in nude mice.
    Liu XF; Zhou XT; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):115-9. PubMed ID: 14969852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel DNA/polymer conjugate for intelligent antisense reagent with improved nuclease resistance.
    Murata M; Kaku W; Anada T; Sato Y; Kano T; Maeda M; Katayama Y
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3967-70. PubMed ID: 14592486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein.
    Moradpour D; Englert C; Wakita T; Wands JR
    Virology; 1996 Aug; 222(1):51-63. PubMed ID: 8806487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential applications of siRNA in hepatitis C virus therapy.
    Smolic R; Volarevic M; Wu CH; Wu GY
    Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and application of novel nucleoside phosphonates and phosphoramidites modified at the base moiety.
    Seela F; Chen Y; Melenewski A; Rosemeyer H; Wei C
    Acta Biochim Pol; 1996; 43(1):45-52. PubMed ID: 8790711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural development studies of anti-hepatitis C virus agents with a phenanthridinone skeleton.
    Nakamura M; Aoyama A; Salim MT; Okamoto M; Baba M; Miyachi H; Hashimoto Y; Aoyama H
    Bioorg Med Chem; 2010 Apr; 18(7):2402-11. PubMed ID: 20303772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of plasminogen activator inhibitor release in endothelial cell cultures by antisense oligodeoxyribonucleotides with a 5'-end lipophilic modification.
    Kobylańska A; Pluskota E; Swiatkowska M; Wójcik M; Cierniewska-Cieślak A; Krakowiak A; Boczkowska M; Pawłowska Z; Okruszek A; Koziołkiewicz M; Cierniewski CS; Stec WJ
    Acta Biochim Pol; 1999; 46(3):679-91. PubMed ID: 10698276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.
    Macejak DG; Jensen KL; Jamison SF; Domenico K; Roberts EC; Chaudhary N; von Carlowitz I; Bellon L; Tong MJ; Conrad A; Pavco PA; Blatt LM
    Hepatology; 2000 Mar; 31(3):769-76. PubMed ID: 10706571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective degradation of targeted mRNAs using partially modified oligonucleotides.
    Dagle JM; Weeks DL
    Methods Enzymol; 2000; 313():420-36. PubMed ID: 10595370
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.
    Vidalin O; Major ME; Rayner B; Imbach JL; Trépo C; Inchauspé G
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2337-44. PubMed ID: 8891141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of oligonucleotide inhibitors of DNA (Cytosine-C5) methyltransferase containing 5-azacytosine residues at specific sites.
    Güimil García R; Brank AS; Christman JK; Marquez VE; Eritja R
    Antisense Nucleic Acid Drug Dev; 2001 Dec; 11(6):369-78. PubMed ID: 11838638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene switching: analyzing a broad range of mutations using steric block antisense oligonucleotides.
    Morcos PA
    Methods Enzymol; 2000; 313():174-89. PubMed ID: 10595356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.